Ketamine Mechanism of Action, Dosage, and Timing in Anesthesia
Introduction to Ketamine
- The American Society of Anesthesiologists notes that ketamine is a dissociative anesthetic with a rapid onset of action (1 minute) and short duration (15-30 minutes) that acts mainly as a non-competitive antagonist of the N-methyl-D-aspartate (NMDA) receptor, producing a cataleptic state that blocks the sensory recognition of painful stimuli and memory 1
Mechanism of Action
- Ketamine is a non-selective and non-competitive antagonist of the N-methyl-D-aspartate (NMDA) receptor, a glutamate ionotropic receptor, producing a functional dissociation between limbic and cortical systems, selectively depressing the cortex and thalamus while stimulating parts of the limbic system 1
- It blocks opioid receptors in the brain and spinal cord, contributing to its analgesic effect 2
Dosage for Anesthesia
- The American College of Emergency Physicians recommends the following dosages:
- The American Society of Anesthesiologists notes that for intramuscular (IM) administration:
Timing of Action
- The onset of action is:
- The duration of action is 15-30 minutes after intravenous administration 2, 1
Clinical Effects
- Produces a dissociative anesthetic state characterized by deep analgesia 5
- Stimulates the cardiovascular and respiratory systems 2
- Does not depress respiratory or cardiovascular reflexes, even when administered at doses 5-100 times higher than intended 2
- Cardiovascular effects: increased blood pressure, heart rate, and cardiac output mediated by sympathetic nervous system stimulation 2
Special Considerations
- Emergency reactions (floating sensations, vivid dreams, hallucinations, and delirium) occur in 10-30% of adults 2
- The use of midazolam in combination with ketamine can minimize these emergency reactions 2
- In children, the combination of ketamine (0.75-2.0 mg/kg) and midazolam (0.05-0.2 mg/kg) has shown fewer complications than midazolam/meperidine regimens 2
Precautions and Contraindications
- Should be avoided in patients with uncontrolled cardiovascular disease, active psychosis, severe hepatic dysfunction, or elevated intracranial/ocular pressure 6
- Produces a dose-dependent increase in heart rate, blood pressure, and cardiac output 2, 1
- Can cause excessive salivation and bronchial secretions 5
Ketamine Administration Routes and Guidelines
Primary Parenteral Routes
- The American Society of Anesthesiologists recommends perioperative pain management with bolus <0.35 mg/kg, followed by continuous infusion at 0.125-0.25 mg/kg/h (maximum 0.5 mg/kg/h) 7
- The American College of Emergency Physicians suggests IM ketamine dosing of 4 mg/kg for wound repair, burn care, or lumbar puncture, and 2.5 mg/kg for laceration repair, with a lower dose being superior to intranasal midazolam 8
Alternative Routes of Administration
- The Anaesthesia society recommends peritonsillar ketamine infiltration for reducing pain and analgesic requirements after tonsillectomy in children, with combination with bupivacaine providing superior analgesia compared to either drug alone 9
- Local infiltration demonstrated superior pain relief compared to IV ketamine in one direct comparison, and subcutaneous ketamine provides similar analgesia to the IV route 10
- The Annals of Emergency Medicine found that intranasal ketamine shows inferior efficacy compared to IM ketamine for procedural sedation 8
- Rectal administration found no differences between peritonsillar, IV, or rectal ketamine in children undergoing tonsillectomy, and topical administration has limited evidence with mixed results 10, 9
Critical Safety Considerations
- The American Heart Association emphasizes that combination with midazolam increases risk of respiratory depression, requiring particular care in monitoring 8
Ketamine Mechanism of Action and Clinical Effects
Secondary Mechanisms Contributing to Analgesia
- At subanesthetic doses, ketamine modulates central sensitization, prevents hyperalgesia, and blocks the development of opioid tolerance through its NMDA antagonism, as supported by the World Journal of Emergency Surgery and the Journal of the National Comprehensive Cancer Network 11, 12
Pharmacokinetics of Ketamine
Absorption and Distribution
- The American Society of Anesthesiologists notes that ketamine has a rapid onset of action when administered intravenously, with a biodisponibility of 100% 13, 14
- The volume of distribution of ketamine is high, with brain levels 10-40 times higher than blood levels, and a high protein binding rate of 90-99% 15
Metabolism and Elimination
- The European Society of Cardiology states that ketamine is extensively metabolized by CYP2B6 and CYP3A4, with a high first-pass metabolism, and its metabolites are excreted mainly through the kidneys 15, 16
- The elimination half-life of ketamine is approximately 2-3 hours in humans, with a small effect of renal insufficiency on the plasma kinetics of the drug and its metabolites 15
Clinical Considerations
- The American Academy of Pediatrics recommends that the duration of analgesic effects of ketamine can persist longer than the anesthetic effect, which lasts 15-30 minutes after intravenous administration 14
- The American College of Clinical Pharmacology notes that small amounts of ketamine remain in body fat deposits for 24-48 hours, but this does not preclude the resumption of normal breastfeeding 13